• Facebook
  • X
  • Instagram
MYELOMA360
  • Home
  • MYBoard
  • MYInsights
  • Strategy & Consulting
  • Contact Us
Select Page

Isa-KRd Elicits Responses in Some With Newly Diagnosed Multiple Myeloma

by | Jul 25, 2024 | Uncategorized

Source: CureToday articles “Patients did great” with a four-drug regimen for multiple myeloma, an expert told CURE®. Read More

My Decision to Receive CAR-T Cell Therapy for Multiple Myeloma

by | Jul 20, 2024 | Uncategorized

Source: CureToday articles I decided to receive CAR-T cell therapy for multiple myeloma when my previous regimen stopped working and now, I’m living my best life. Read More

Finding Support After a Myeloma Diagnosis

by | Jul 12, 2024 | Uncategorized

Source: CureToday articles I was diagnosed with myeloma more than two decades ago and am lucky to have support throughout. Read More

My Lifestyle as Someone With Multiple Myeloma

by | Jul 11, 2024 | Uncategorized

Source: CureToday articles Side effects from multiple myeloma, such as six inches of collapsed vertebrae, have made me adjust my lifestyle, but I make the most of what I can. Read More

How Bispecific Antibodies Work to Treat Multiple Myeloma

by | Jul 8, 2024 | Uncategorized

Source: CureToday articles One expert explains how bispecific antibodies are a ‘targeted and effective’ option for patients with multiple myeloma. Read More

Mapping the Proteogenomic Landscape of Multiple Myeloma: Implications for Targeted Therapy

by | Jul 8, 2024 | Uncategorized

Source: Pharmacy Times articles Researchers identify significant proteins involved in the growth and survival of malignant multiple myeloma cells. Read More
« Older Entries
Next Entries »

Recent Content

  • Refining precision prognostics in multiple myeloma: loss of miR-221/222 cluster in CD138+ plasma cells results in short-term progression and worse treatment outcome
  • Myeloma Awareness Month and Acknowledging Early Symptoms of The Disease
  • Daratumumab-based quadruplet versus triplet induction regimens in transplant-eligible newly diagnosed multiple myeloma: a systematic review and meta-analysis
  • Daratumumab-based quadruplet versus triplet induction regimens in transplant-eligible newly diagnosed multiple myeloma: a systematic review and meta-analysis
  • Correction: Multiple myeloma as a challenging multidimensional random process: a data-driven web-based application for treatment selection
  • Genetic Study Sheds Light on Inherited Risk of Multiple Myeloma
  • A real-world experience of efficacy and safety of belantamab mafodotin in relapsed refractory multiple myeloma
  • Expert Explains Early Signs, Treatment Advances and Care in Multiple Myeloma
  • Treatment of Multiple Myeloma in Patients Refractory to Daratumumab/Anti-CD38 Monoclonal Antibodies: A Systematic Review
  • Pharmacists Play an Essential Role in Bispecific Therapy for Multiple Myeloma
  • Facebook
  • X
  • Instagram
©2016-2024 MYELOMA360
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
SettingsAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT